Key Articles and Guidelines for the Prevention of Venous Thromboembolism

被引:11
作者
Dobesh, Paul P. [1 ]
Wittkowsky, Ann K. [2 ,3 ]
Stacy, Zachary [4 ,5 ]
Dager, William E. [6 ,7 ,8 ]
Haines, Stuart T. [9 ,10 ]
Lopez, Larry M. [11 ]
Nutescu, Edith [12 ,13 ,18 ]
Phillips, Katherine W. [14 ]
Trujillo, Toby C. [15 ,16 ]
Vondracek, Tom [17 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Pharm Practice, Coll Pharm, Omaha, NE 68198 USA
[2] Univ Washington, Sch Pharm, Seattle, WA 98195 USA
[3] Univ Washington, Anticoagulat Serv, Med Ctr, Seattle, WA 98195 USA
[4] St Lukes Hosp, Dept Pharm, Chesterfield, MO USA
[5] St Louis Coll Pharm, Div Pharm Practice, St Louis, MO USA
[6] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA
[7] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA
[8] Univ Calif Davis, Sch Med, Sacramento, CA USA
[9] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[10] W Palin Beach Vet Affairs Med Ctr, Dept Pharm, W Palm Beach, FL USA
[11] Univ Florida, Coll Pharm & Med, Dept Pharm Practice, Gainesville, FL USA
[12] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA
[13] Univ Illinois, Ctr Pharmacoecon Res, Chicago, IL USA
[14] Boston Med Ctr, Dept Pharm, Boston, MA USA
[15] Univ Colorado, Sch Pharm, Dept Clin Pharm, Denver, CO 80202 USA
[16] Univ Colorado Hosp, Denver, CO USA
[17] Exempla St Joseph Hosp, Dept Pharm, Denver, CO USA
[18] Univ Illinois, Antithrombosis Ctr, Med Ctr, Chicago, IL USA
来源
PHARMACOTHERAPY | 2009年 / 29卷 / 04期
关键词
anticoagulation; evidence-based medicine; pharmacy practice;
D O I
10.1592/phco.29.4.410
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Venous thromboembolism (VTE) is an important medical problem that affects millions of patients each year. With appropriate prophylaxis, many of these thromboembolic events can be prevented. Although strong evidence supporting VTE prophylaxis spans several decades, several large American and global registries have documented very poor use of appropriate prophylaxis. Because of increasing regulatory requirements, hospitals nationwide are in the process of developing documentation of appropriate VTE prophylaxis programs for both surgical and medical patients. A wide range of clinicians must understand what constitutes appropriate VTE prophylaxis in various patient populations. With the existence of numerous pharmacologic agents, abundance of data from major clinical trials, and several nationally recognized clinical guidelines, compiling the needed reference material to make evidence-based decisions on appropriate VTE prophylaxis can be difficult for clinicians. Therefore, we provide a bibliography of key articles and guidelines related to the prevention of VTE in various patient groups. We hope this compilation will serve as a resource for pharmacists, physicians, nurses, residents, and students responsible for the care of patients who may be at risk for VTE.
引用
收藏
页码:410 / 458
页数:49
相关论文
共 8 条
[1]
Geerts W.H., Bergqvist D., Pineo G.F., Et al., Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines, 133, SUPPL. 6, (2008)
[2]
Zhan C., Miller M.R., Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization, JAMA, 290, pp. 1868-1874, (2003)
[3]
Dobesh P.P., Brouse S.D., Johnson D.C., Et al., Key articles and guidelines relative to treatment of patients with acute coronary syndromes, Pharmacotherapy, 24, pp. 105-144, (2004)
[4]
Cheng J.W.M., Frank L., Garrett S.D., Lu Y., Sanoski C.A., White C.M., Key articles and guidelines in pharmacotherapeutic management of arrhythmias, Pharmacotherapy, 24, pp. 248-279, (2004)
[5]
de Denus S., Hardy A.M., Olsen K.L., Robinette B., Key articles and guidelines in the management of hypertension, Pharmacotherapy, 24, pp. 1385-1399, (2004)
[6]
Ng T.M.H., Carter O., Guillory G., Et al., High-impact articles related to the pharmacotherapeutic management of systolic heart failure, Pharmacotherapy, 24, pp. 1594-1633, (2004)
[7]
Ito M.K., Cheung R.J., Gupta E.K., Et al., Key articles, guidelines, and consensus papers relative to the treatment of dyslipidemias-2005, Pharmacotherapy, 26, pp. 939-1010, (2006)
[8]
Dobesh P.P., Brouse S.D., Dager W.E., Spinler S.A., Stacy Z., Wiggins B.S., Key articles and guidelines in the management of acute coronary syndromes and in percutaneous coronary intervention: 2007 update, Pharmacotherapy, 27, pp. 1722-1758, (2007)